OTC:SMNR | Cash Flow Statement | Semnur Pharmaceuticals, Inc.

Complete source-backed cash-flow history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$4.35M
2026-03-31-$4.58M-$2.67M$2.75M
2025-12-31-$6.16M-$3.61M$3.54M
2025-09-30-$152.59M
2025-06-30-$999,000.00
2025-03-31-$665,000.00-$399,000.00$394,000.00
2024-12-31-$776,000.00-$1.41M$0.00$0.00$1.41M
2024-09-30-$1.3M
2024-06-30-$1.11M
2024-03-31-$1.51M-$374,151.00$170,700.00
2023-12-31$553,343.00-$158,996.00$40.54M-$40.19M
2023-09-30$630,586.00
2023-06-30$457,709.00
2023-03-31-$1.01M-$240,397.00$0.00
2022-12-31-$684,668.00-$165,831.00$0.00$0.00
2022-09-30$307,468.00
2022-06-30-$30,847.00
2022-03-31-$11,343.00$0.00$16,567.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$160.42M-$5.87M$5.88M
2024-12-31-$4.69M-$4.89M$43.43M$43.43M$4.89M
2023-12-31$632,536.00-$632,783.00$39.71M$40.54M-$39.69M
2022-12-31-$419,390.00-$426,095.00-$84.15M$85.4M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.